Lung cancer screening eligibility expanded by USPSTF
PARA PUBLICACIÓN INMEDIATA
Contacto: Lisa Berry Edwards
703-519-2107
Lisa.Edwards@preventcancer.org
Alexandria, VA—The U.S. Preventive Services Task Force (USPSTF) today released new guidelines on lung cancer screening. The USPSTF gave a “B” grade for lung cancer screening for people ages 50-80 with a 20 pack-year history who currently smoke or have quit within the last 15 years. (A “pack-year” is the equivalent of smoking one pack per day for a year.) Under the Affordable Care Act, insurance companies must cover screening services given an “A” or “B” grade from the USPSTF.
In previous recommendations published in 2013, the USPSTF recommended lung cancer screening for those ages 55-80 with a 30 pack-year history. By lowering the eligible screening age and smoking criteria, the USPSTF has effectively expanded screening access to millions more smokers or former smokers. According to The Washington Post, the change means that 15 million people will now be eligible for lung cancer screening.
The Foundation applauds the USPSTF for expanding access to screening with these new guidelines. However, in our comments to the USPSTF submitted last year based on then-draft guidelines for lung cancer screening, we urged the USPSTF to go even further by expanding the “look-back” requirement for former smokers (currently 15 years) and including additional risks for lung cancer in the eligibility guidelines, such as environmental tobacco smoke and risks not related to tobacco, such as occupational exposures and exposure to radon. Implementing these changes would go further in expanding access to screening and reducing lung cancer health disparities for Black people and women.
La Fundación para Prevenir el Cáncer® has long been an advocate for lung cancer screening. In 2000, the Foundation launched the Millennium Lung Cancer Workshop (now the Taller de Imagen Cuantitativa), which led to the National Cancer Institute (NCI) undertaking the National Lung Cancer Screening Trial. This is the largest clinical trial ever sponsored by the NCI. The trial proves that lung cancer screening of high-risk individuals can reduce lung cancer mortality by at least 20%.
Learn more about how to reduce your risk of cáncer de pulmón.
Acerca de la Fundación Prevent Cancer®
La Fundación para Prevenir el Cáncer® is celebrating 35 years as the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.
La Fundación está avanzando para afrontar el desafío de reducir las muertes por cáncer en 40% para 2035. Para lograrlo, nos comprometemos a invertir $20 millones en tecnologías innovadoras para detectar el cáncer tempranamente y avanzar en la detección de múltiples cánceres, $10 millones para ampliar la detección del cáncer y la vacunación. acceso a comunidades médicamente desatendidas, y $10 millones para educar al público sobre las opciones de detección y vacunación.
Para mayor información por favor visite www.preventcancer.org.